HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Radiotherapy and Oncology

• Publication date

  2009-05-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.radonc.2010.12.009PMID 21295878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer.

  2010cited by this paper
• CyberKnife Stereotactic Radiotherapy as Monotherapy for Low- to Intermediate-Stage Prostate Cancer: Early Experience, Feasibility, and Tolerance

  2010cited by this paper
• A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible.

  2010influential reference
• Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer.

  2009influential reference
• Current status and perspectives of brachytherapy for prostate cancer

  2009cited by this paper
• 70 oral: Clinical Outcome of Interstitial High Dose Rate (HDR) Brachytherapy + External Beam Radiotherapy (EBRT) for Early Stage Prostate Cancer

  2009cited by this paper
• Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.

  2009cited by this paper
• Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.

  2008cited by this paper
• A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer.

  2008cited by this paper
• HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging.

  2008cited by this paper
• High dose rate brachytherapy for prostate cancer.

  2008cited by this paper
• Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR.

  2007cited by this paper
• Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants.

  2006cited by this paper
• GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.

  2005cited by this paper
• Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy.

  2004cited by this paper
• 3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer

  2004cited by this paper
• Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions.

  2004cited by this paper
• Dose uncertainty due to computed tomography (CT) slice thickness in CT-based high dose rate brachytherapy of the prostate cancer.

  2004cited by this paper
• Anatomy based inverse planning in HDR prostate brachytherapy.

  2004cited by this paper
• High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions.

  2003influential reference
• Determination of the accuracy of implant reconstruction and dose delivery in brachytherapy in The Netherlands and Belgium.

  2001cited by this paper
• Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.

  2001cited by this paper
• High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.

  2000cited by this paper
• Needle displacement during HDR brachytherapy in the treatment of prostate cancer.

  2000influential reference
• Urological Survey: AbstractsHigh Dose-Rate Afterloading 192Iridium Prostate Brachytherapy: Feasibility Report

  1999cited by this paper
• High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.

  1998cited by this paper

• Reconstruction errors in clinical intraoperative TRUS-based prostate HDR-BT detected using electromagnetic tracking.

  2024cites this paper
• Assessment of integrated electromagnetic tracking for dwell position monitoring in a clinical HDR brachytherapy setting for prostate cancer.

  2024cites this paper
• Therapeutic prostate cancer interventions: a systematic review on pubic arch interference and needle positioning errors

  2024cites this paper
• Dosimetric benefits and preclinical performance of steerable needles in HDR prostate brachytherapy.

  2024cites this paper
• In vivo dosimetry in pelvic brachytherapy

  2022cites this paper
• Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

  2021cites this paper
• Accuracy of dwell-position detection with a combined electromagnetic tracking brachytherapy system for treatment verification in pelvic brachytherapy.

  2020cites this paper
• Fast automated multi-criteria planning for HDR brachytherapy explored for prostate cancer

  2019cites this paper
• High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

  2018cites this paper
• An evaluation of our experience in position verification of catheters used for interstitial high-dose-rate brachytherapy of solitary bladder tumors.

  2017cites this paper
• The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer.

  2017cites this paper
• Automated Treatment Planning in HDR Brachytherapy for Prostate Cancer

  2017cites this paper
• Focal MRI guided brachytherapy for prostate cancer

  2017cites this paper
• Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.

  2017cites this paper
• HDR brachytherapy as monotherapy for low risk prostate cancer: dosimetric and clinical evaluation

  2016cites this paper
• Hypofractionated radiotherapy for prostate cancer: how far can we go?

  2016influential citation
• Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: Does implant displacement and its correction influence acute and late toxicity?

  2016cites this paper
• High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer: Clinical Results for a Median 8-Year Follow-Up.

  2016cites this paper
• Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer.

  2015cites this paper
• High-dose-rate brachytherapy as monotherapy for prostate cancer.

  2014cites this paper
• Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM☆

  2014cites this paper
• High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

  2014cites this paper
• Catheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of prostate cancer patients

  2014cites this paper
• Characterization of implant displacement and deformation in gynecologic interstitial brachytherapy.

  2014cites this paper
• State of the Art Review High-dose-rate brachytherapy as monotherapy for prostate cancer

  2014cites this paper
• The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer

  2014cites this paper
• High-dose-rate prostate brachytherapy based on registered transrectal ultrasound and in-room cone-beam CT images.

  2014cites this paper
• The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer

  2013cites this paper
• Deviations from the planned dose during 48 hours of stepping source prostate brachytherapy caused by anatomical variations.

  2013influential citation
• Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy?

  2013cites this paper
• High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience.

  2012cites this paper
• HDR-brachytherapie gecombineerd met uitwendige radiotherapie voor laag- en intermediair risico prostaatcarcinoom: 7 jaren ervaring

  2012cites this paper
• Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations.

  2012cites this paper
• Daily CT measurement of needle applicator displacement during multifractionated high-dose-rate interstitial brachytherapy for postoperative recurrent uterine cancer.

  2012cites this paper
• Prostate HDR brachytherapy catheter displacement between planning and treatment delivery.

  2011cites this paper
• Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

  2011cites this paper
• Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy.

  2011cites this paper
• Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.

  2011cites this paper